← FDA Drug Approvals (Drugs@FDA)

EZETIMIBE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORIENT PHARMA · Approved 2022-09-13

Drug application

FDA Application #

ANDA215693

Application type

Abbreviated New Drug Application (Generic)

Brand name

EZETIMIBE

Generic name

EZETIMIBE

Active ingredients

EZETIMIBE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ORIENT PHARMA

Manufacturer

Marlex Pharmaceuticals, Inc.

First approval

2022-09-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown